Transdermal

This page contains recent news articles, when available, and an overview of Transdermal but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.

KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results  -  11 Aug 2008
Having received approval for Evamist(TM) from the FDA in July 2007, the Company has had a successful launch of this patented estradiol transdermal spray MarketWatch

Watson Announces Limited Recall of Fentanyl  -  11 Aug 2008
Watson Pharmaceuticals is voluntarily recalling one lot of 75 mcg/hr fentanyl transdermal system patches sold in the US from wholesalers and pharmacies. FDA news (subscription),

Ortho Biotech recalls Procrit batch  -  11 Aug 2008
Meanwhile, Watson Pharmaceuticals has announced it is recalling a batch of its 75 mcg/hr Fentanyl Transdermal System patches sold in the US due to a fault. Hays Pharma,

BioSante Pharmaceuticals Reports Second Quarter 2008 Developments ...  -  11 Aug 2008
This significantly increases the potential market opportunity for LibiGel, a transdermal testosterone gel in Phase III clinical development for the PR-Inside.com (Pressemitteilung),

Emisphere Technologies, Inc. Announces 2008 Second Quarter ...  -  11 Aug 2008
...can be applied to the oral route of administration as well other delivery pathways, such as buccal, per rectum, pulmonary, intra-vaginal or transdermal. MarketWatch

KV Pharmaceutical Company Reports Fiscal 2009 First Quarter Results  -  11 Aug 2008
...balance of fiscal 2009 helped by recent introductions like metoprolol succinate extended-release tablets and our branded transdermal spray Evamist(TM). Biloxi Sun Herald,

BioSante Pharmaceuticals Reports Second Quarter 2008 Developments ...  -  11 Aug 2008
This significantly increases the potential market opportunity for LibiGel, a transdermal testosterone gel in Phase III clinical development for the Business Wire (press release),

Trends in Oral Contraception: An Expert Interview With Dr. Andrew ...  -  11 Aug 2008
All combination estrogen-progestin contraceptives, meaning combination OCs, as well as the transdermal contraceptive or patch and the estrogen-progestin Medscape (subscription)

/CORRECTION -- Watson Pharmaceuticals, Inc./  -  Aug 8, 2008
Anyone who has 75 mcg/hr Fentanyl Transdermal System patches should check the box or foil pouch for the lot number and expiration date to see if they have Biloxi Sun Herald,

Varenicline Better Than Transdermal Nicotine Replacement to Quit ...  -  Aug 7, 2008
Compare the effects of varenicline vs transdermal nicotine replacement therapy on continuous abstinence rate for the last 4 weeks of the treatment period in Medscape (subscription)

BioSante Pharma Announces Its Re-Acquisition of Elestrin  -  Aug 10, 2008
The total, single-entity US estrogen therapy market is estimated at about $1.4 billion in annual sales, of which the transdermal segment, mostly patches, Seeking Alpha,

Altea Therapeutics Forms Premier Scientific Advisory Board  -  Aug 8, 2008
...“Now that our novel transdermal delivery technology is demonstrating clinical effectiveness for drugs that were previously administered as injections, Business Wire (press release),

Frost & Sullivan Honours TransPharma Medical for its Innovative ...  -  Aug 1, 2008
The unique ViaDerm system solution allows for low-cost, patient-friendly transdermal delivery of a wide variety of drugs from a patch. MarketWatch

Estrogen Patches Effective for Androgen Ablation in Prostate Cancer  -  Aug 8, 2008
By David Douglas NEW YORK AUG 08, 2008 (Reuters Health) - Early data from a multicenter phase II trial using transdermal estrogen patches as first-line Cancerpage.com,

Vyteris transdermal peptide delivery completes Phase I  -  Jul 29, 2008
By Nick Taylor 29-Jul-2008 - Vyteris has successfully completed a Phase I dose ranging study for its Smart Patch transdermal system for delivery of a In-PharmaTechnologist.com,

World-First Breakthrough for Women's Sexual Satisfaction  -  Jul 31, 2008
This scientific development is the basis of a new transdermal gel which is applied topically by patients. It was developed jointly by NxGen Pharmaceuticals MarketWatch

Noven Announces Triggering of $25 Million Daytrana(R) Sales Milestone  -  Aug 4, 2008
...today announced that it has been advised by Shire Limited that Shire's net sales of Daytrana(R) (methylphenidate transdermal system) have triggered the MarketWatch

Echo Therapeutics Announces Publication of Positive Clinical Data ...  -  Jul 14, 2008
Echo Therapeutics (OTC Bulletin Board: ECTE) today announced publication of results from three pilot clinical studies of its Symphony Transdermal Continuous Stockhouse,

Transdermal Rather Than Oral Hormone Therapy May Help Avoid ...  -  Jul 16, 2008
Use of transdermal hormone therapy rather than oral therapy in a 5-year period could avoid 1 cholecystectomy in every 140 users, according to the results of Medscape (subscription)

Solid Microstructured Transdermal Delivery Highlighted at ...  -  Jul 17, 2008
St. Paul, MN (July 15)—3M Drug Delivery Systems successfully designed a proof of concept device using a solid microstructured transdermal system (sMTS) for Pharmaceutical Technology Magazine,

Infinity BathTea Systems Reformulates Its Transdermal Hydrotherapy ...  -  Jul 17, 2008
Infinity BathTea Systems has announced the reformulation of its line of transdermal hydrotherapy products. The firm claims that the reformulated products RedOrbit,

Vyteris to Pursue Development of Pain Medication Compounds  -  Aug 6, 2008
Haro Hartounian, president of Vyteris, said: "Our first successful FDA approval for our active patch transdermal system was for topical delivery of RedOrbit,

Nuvo announces proposed amendments to outstanding convertible ...  -  Aug 1, 2008
Nuvo is focused on the research and development of drug products delivered to and through the skin using its topical and transdermal drug delivery FOXBusiness

Vyteris, Inc. Receives $2.5 Million Loan from Ferring ...  -  Jul 21, 2008
...manufacturer of the first FDA-approved active patch transdermal drug delivery system, received $2.5 million principal amount of financing effective on July MarketWatch

Mylan buys out Watson’s interest in Somerset Pharmaceuticals  -  Jul 29, 2008
Somerset developed Emsam, a transdermal patch for the treatment of depression. Emsam is marketed in the United States by New York-based Bristol-Myers Squibb Bizjournals.com,

RedChip Visibility Issues First Quarter 2008 Research Update On ...  -  Jul 26, 2008
The Company recently announced another clinical trial for its Symphony Transdermal Continuous Glucose Monitoring System from which data is expected in the FOXBusiness

DURECT Corporation Announces Second Quarter 2008 Financial Results  -  Aug 5, 2008
Bupivacaine is the active pharmaceutical ingredient in ELADUR, DURECT's investigational transdermal drug patch. If ELADUR is the first bupivacaine product MarketWatch

Echo Therapeutics Announces Positive Results of a Clinical Study ...  -  Jul 29, 2008
Echo's non-invasive Symphony tCGM System consists of its wireless transmission and transdermal biosensor technologies and the Prelude(TM) SkinPrep System, Canada NewsWire (press release),

Vyteris Announces Successful Completion of Peptide Dose Ranging ...  -  Jul 28, 2008
In the Phase I dose ranging study, four different electronic profiles were used to control the transdermal delivery of the peptide from patches loaded with Business Wire (press release),

Vyteris to Pursue Joint Development Agreements  -  Aug 5, 2008
The company said it has marketing approval from the US Food and Drug Administration for its transdermal technology. Vyteris said its technology could NJBIZ,

Estrogen Relieves Psychotic Symptoms in Women With Schizophrenia  -  Aug 7, 2008
Describe the effect of transdermal estradiol on symptoms of schizophrenia in women. Identify potential mechanisms for a therapeutic effect of estradiol for Medscape (subscription)

Pfizer: shooting itself in the foot with Chantix study  -  Jul 30, 2008
The key conclusion of the study was that abstinence from smoking was greater at the end of treatment with Chantix than with transdermal nicotine replacement Trading Markets (press release),

3M gets under the skin of drug delivery  -  Jul 17, 2008
3M has been working on transdermal technologies for 30 years, with the company previously using it for the delivery of vaccines but this latest development In-PharmaTechnologist.com,

Applied Wellness to Release Proprietary Nutritional Skin Patch  -  Jul 24, 2008
The soon-to-be sold anti-aging patch is one of several transdermal patches Advanced Wellness plans to bring to market in coming months. Market Wire (press release)

Head-to-Head Study Results Demonstrated No Significant Difference ...  -  Jul 28, 2008
PARSIPPANY, NJ, July 28 /Xinhua-PRNewswire/ -- New data published today in the August issue of Thorax, entitled ‘Varenicline versus transdermal nicotine �?�富財經,

New Treatment for Chronic Non-healing Wounds Unveiled  -  Jul 28, 2008
According to Robert Winston, MD, using a transdermal delivery system allows antibiotic dosage 40 to 60 times greater than achieved by IV administration, Emailwire

BioSante Pharmaceuticals Announces Reacquisition of Elestrin™, FDA ...  -  Aug 7, 2008
The total, single-entity US estrogen therapy market is estimated at approximately $1.4 billion in annual sales, of which the transdermal segment, Business Wire (press release),

PolyDerm For Beautiful Skin--the Next Level in the Evolution of ...  -  Jul 14, 2008
PolyDerm is the New Generation of transdermal creams that work fast and effectively to heal and repair the layers of the skin. Dr. Mary Schrick and Paul PR Web (press release),

Noven Pharmaceuticals Inc - Corporate and Strategic Assessment ...  -  Jul 17, 2008
The company markets a portfolio of hormone therapy products including Vivelle Dot, CombiPatch and Daytrana developed using its proprietary transdermal drug PR-Inside.com (Pressemitteilung),

Business briefing  -  Aug 9, 2008
A "small number" of Fentanyl Transdermal System patches sold from Jan. 30 to March 19 leaked fentanyl gel, Watson said in a statement. Los Angeles Times,

Noven Announces 2008 Second Quarter Financial Results  -  Aug 6, 2008
Gross margin in the first half of 2008 was adversely affected by inventory write-offs and costs associated with the equipment failure in transdermal Business Wire (press release),

Synergism between Oral Estrogen Therapy and Cytochrome P450 3A5*1 ...  -  Aug 6, 2008
By contrast, there was no significant interaction between CYP3A5*1 allele and transdermal estrogen on VTE risk. There is no interaction between CYP1A2 Journal of Clinical Endocrinology and Metabolism,

Novel Drug Delivery Mechanisms Offer Significant Potential for the ...  -  Jul 24, 2008
The analysis also finds that the European transdermal drug delivery market earned revenues of USD 4.04 billion in 2007 and estimates this to reach USD 7.87 MarketWatch

Head-to-head Study Results Demonstrated No Significant Difference ...  -  Jul 28, 2008
The Thorax paper, entitled, "Varenicline versus transdermal nicotine patch for smoking cessation: results from a randomised open-label trial", Earthtimes (press release),

Your Whole Pet  -  Jul 21, 2008
For instance, some medications can be compounded into a transdermal form, given by applying a gel or patch to the skin. A word of warning: Not all drugs San Francisco Chronicle,

Optimizing Pain Control With Fentanyl Patches  -  Jul 15, 2008
In patients receiving high transdermal doses (multiple patches), body surface area may also play an important role in absorption. Medscape (subscription)

Expert Available For Menopause Awareness Month To Discuss New ...  -  Aug 9, 2008
BioSante's lead products include LibiGel® (transdermal testosterone gel) in Phase III clinical development by BioSante under a US Food and Drug Medical News Today (press release),

Emisphere Announces Recruitment of Novartis Phase III Study for ...  -  Aug 5, 2008
...can be applied to the oral route of administration as well other delivery pathways, such as buccal, rectal, inhalation, intra-vaginal or transdermal. MarketWatch

Shire Delivers Strong Quarter: Driven by $243m of New Product ...  -  Jul 31, 2008
DAYTRANA(TM) (methylphenidate transdermal system) for use in children in the EU in 2009 and adolescents in the US in 2010; and - Velaglucerase alfa for MarketWatch

Safeguard Scientifics Announces Second Quarter 2008 Financial Results  -  Aug 7, 2008
SmartRelief(TM) transdermal patch for the relief of migraines, a condition suffered by an estimated 26 million people annually in the United States. Trading Markets (press release),

:

Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on health.mongabay.com lead to other sites. health.mongabay.com does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is health.mongabay.com responsible for dead or misdirected links.